Literature DB >> 10966065

A randomized trial of the effect of single-vision vs. bifocal lenses on myopia progression in children with esophoria.

G W Fulk1, L A Cyert, D E Parker.   

Abstract

BACKGROUND: Bifocals have long been thought to reduce progression of childhood myopia. However, this hypothesis has not been definitively evaluated.
METHODS: We conducted a randomized clinical trial to test the hypothesis that bifocals slow myopia progression in children with near-point esophoria. Eighty-two myopic children were randomized to single-vision glasses (n = 40) or to bifocals with a +1.50 D add (n = 42) and were followed for 30 months. Refraction was measured by an automated refractor after cycloplegia. The primary outcome was myopia progression defined as the difference between the spherical equivalent at baseline and at the 30-month examination, averaged over both eyes.
RESULTS: Follow-up was incomplete for six children in the bifocal group and one child in the single-vision group. Among the children completing the 30 months of follow up, myopia progression (mean spherical equivalent of the two eyes) averaged 0.99 D for bifocals and 1.24 D for single vision (unadjusted, p = 0.106; adjusted for age, p = 0.046). Treatment groups differed in their cumulative distributions (Kolmogorov-Smirnov procedure, p = 0.031). Evidence for a treatment effect on growth in vitreous chamber depth was similar (p = 0.046 by K.S.).
CONCLUSION: Use of bifocals, instead of single-vision glasses, by children with near-point esophoria seemed to slow myopia progression to a slight degree.

Entities:  

Mesh:

Year:  2000        PMID: 10966065     DOI: 10.1097/00006324-200008000-00006

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  49 in total

Review 1.  Interventions to slow progression of myopia in children.

Authors:  Jeffrey J Walline; Kristina Lindsley; Satyanarayana S Vedula; Susan A Cotter; Donald O Mutti; J Daniel Twelker
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 2.  Myopia progression rates in urban children wearing single-vision spectacles.

Authors:  Leslie Donovan; Padmaja Sankaridurg; Arthur Ho; Thomas Naduvilath; Earl L Smith; Brien A Holden
Journal:  Optom Vis Sci       Date:  2012-01       Impact factor: 1.973

3.  The effective add inherent in 2-zone negative lenses inhibits eye growth in myopic young chicks.

Authors:  Yue Liu; Christine Wildsoet
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-31       Impact factor: 4.799

4.  The effect of two-zone concentric bifocal spectacle lenses on refractive error development and eye growth in young chicks.

Authors:  Yue Liu; Christine Wildsoet
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

5.  Monovision slows juvenile myopia progression unilaterally.

Authors:  J R Phillips
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

6.  Progressive-addition lenses versus single-vision lenses for slowing progression of myopia in children with high accommodative lag and near esophoria.

Authors: 
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-25       Impact factor: 4.799

7.  Accommodation in emmetropic and myopic young adults wearing bifocal soft contact lenses.

Authors:  Janice Tarrant; Holly Severson; Christine F Wildsoet
Journal:  Ophthalmic Physiol Opt       Date:  2008-01       Impact factor: 3.117

Review 8.  Practical applications to modify and control the development of ametropia.

Authors:  P R Sankaridurg; B A Holden
Journal:  Eye (Lond)       Date:  2013-12-06       Impact factor: 3.775

Review 9.  Optical treatment strategies to slow myopia progression: effects of the visual extent of the optical treatment zone.

Authors:  Earl L Smith
Journal:  Exp Eye Res       Date:  2013-01-03       Impact factor: 3.467

10.  Accommodative lag and juvenile-onset myopia progression in children wearing refractive correction.

Authors:  David A Berntsen; Loraine T Sinnott; Donald O Mutti; Karla Zadnik
Journal:  Vision Res       Date:  2011-02-20       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.